Tacrolimus toxicity-related chorea in an infant after liver transplantation
- PMID: 35977888
- PMCID: PMC9475155
- DOI: 10.4266/acc.2021.01431
Tacrolimus toxicity-related chorea in an infant after liver transplantation
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
References
-
- Op den Buijsch RA, Christiaans MH, Stolk LM, Vries JE, Cheung CY, Undre NA, et al. Tacrolimus pharmacokinetics and pharmacogenetics: influence of adenosine triphosphate-binding cassette B1 (ABCB1) and cytochrome (CYP) 3A polymorphisms. Fundam Clin Pharmacol. 2007;21:427–35. - PubMed
-
- Dawson TM. Immunosuppressants, immunophilins, and the nervous system. Ann Neurol. 1996;40:559–60. - PubMed
-
- Mroué A, Azar H. Improvement of a post pump chorea after switching to a low dose tacrolimus regimen in a kidney transplant recipient: a case report. J Urol Ren Dis. 2018;198
-
- Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation. Clin Pharmacokinet. 2004;43:623–53. - PubMed
LinkOut - more resources
Full Text Sources
